Company Filing History:
2 out of 687 
1 out of 9,166 
Years Active: 2015-2017
Title: Wei-Chen Hsieh: Innovator in RNA Therapeutics
Introduction
Wei-Chen Hsieh is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of small interfering RNA (siRNA) technologies. With two patents to his name, his work stands out in the realm of biological research and medical innovation.
Latest Patents
Hsieh's most recent patents focus on a small interfering RNA and pharmaceutical compositions aimed at inhibiting galectin-12 expression. His developed small interfering RNA includes a passenger strand and a guide strand designed to target specific sequences. The inventions provide methods for treating disorders associated with excessive sebocyte proliferation and lipid content. These innovative approaches utilize a pharmaceutical composition that includes either a small molecule inhibitor or a nucleic acid-based inhibitor, which are essential for reducing galectin-12 activity and altering cell functions in human sebocytes.
Career Highlights
Throughout his career, Wei-Chen Hsieh has collaborated with prestigious institutions such as Academia Sinica and the Industrial Technology Research Institute. His research has propelled him into the spotlight within the scientific community, and his patents have the potential to advance therapeutic strategies significantly.
Collaborations
Hsieh has worked alongside notable colleagues, including Fu-Tong Liu and Yen-Ju Lin. These collaborations enhance his innovative efforts, bringing together diverse expertise to tackle complex challenges in biotechnology and pharmacology.
Conclusion
Wei-Chen Hsieh's innovative work in small interfering RNA and associated compositions marks him as a key figure in the advancement of therapeutic modalities. With his focus on inhibiting galectin-12, Hsieh is set to impact the future of treatments for disorders linked to sebocyte function. His patents reflect a commitment to addressing critical issues in health and medicine, underlining the importance of innovation in driving breakthroughs.